JS
Joseph C Scodari
Director

Joseph C Scodari insider trades: Acurx Pharmaceuticals (ACXP) stock buys and sales

Director, Acurx Pharmaceuticals Last trade Jan 6, 2025 67 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2006
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Joseph reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 6, 2025ACXP↑ Buy$25K
May 10, 2021OPTN↑ Buy$30K
Mar 6, 2020OPTN↑ Buy$50K
Dec 6, 2019OPTN↑ Buy$50K
Dec 12, 2018OPTN↑ Buy$51K
Jun 24, 2011CVD↑ Buy$46K
Jun 17, 2010CVD↑ Buy$11K
Aug 12, 2008CVD↑ Buy$49K
Aug 4, 2008ENDP↑ Buy$49K
May 28, 2008JNJ↓ Sell$4.2M
Oct 24, 2006JNJ↓ Sell$4.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Joseph C Scodari's insider trades

Joseph C Scodari is a director at Acurx Pharmaceuticals (ACXP). Since Oct 24, 2006, Joseph has reported 9 open-market purchases worth $360K and 2 sales worth $8.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (49 filings), option exercises (13 filings), other transactions (7 filings), shares returned to the company (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.